Scandium Radioisotopes-Toward New Targets and Imaging Modalities
- PMID: 38005390
- PMCID: PMC10675654
- DOI: 10.3390/molecules28227668
Scandium Radioisotopes-Toward New Targets and Imaging Modalities
Abstract
The concept of theranostics uses radioisotopes of the same or chemically similar elements to label biological ligands in a way that allows the use of diagnostic and therapeutic radiation for a combined diagnosis and treatment regimen. For scandium, radioisotopes -43 and -44 can be used as diagnostic markers, while radioisotope scandium-47 can be used in the same configuration for targeted therapy. This work presents the latest achievements in the production and processing of radioisotopes and briefly characterizes solutions aimed at increasing the availability of these radioisotopes for research and clinical practice.
Keywords: radiochemical separation; radiolabeling; radiopharmaceuticals; scandium radioisotopes; theranostics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.Int J Mol Sci. 2024 May 29;25(11):5954. doi: 10.3390/ijms25115954. Int J Mol Sci. 2024. PMID: 38892142 Free PMC article. Review.
-
Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47.Curr Radiopharm. 2021;14(4):359-373. doi: 10.2174/1874471014999210112205535. Curr Radiopharm. 2021. PMID: 33438551
-
Production and purification of Scandium-47: A potential radioisotope for cancer theranostics.Appl Radiat Isot. 2016 Dec;118:124-130. doi: 10.1016/j.apradiso.2016.09.004. Epub 2016 Sep 6. Appl Radiat Isot. 2016. PMID: 27640172
-
Development of bone seeker radiopharmaceuticals by Scandium-47 and estimation of human absorbed dose.Appl Radiat Isot. 2017 Nov;129:108-116. doi: 10.1016/j.apradiso.2017.07.062. Epub 2017 Aug 1. Appl Radiat Isot. 2017. PMID: 28843158
-
Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept.Cancer Biother Radiopharm. 2018 Oct;33(8):316-329. doi: 10.1089/cbr.2018.2485. Epub 2018 Sep 28. Cancer Biother Radiopharm. 2018. PMID: 30265573 Review.
Cited by
-
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48Ti Targets for the Production of Theranostic 47Sc Radionuclide, 46cSc, 44mSc, 44gSc, 43Sc, and 48V.Pharmaceuticals (Basel). 2023 Dec 23;17(1):26. doi: 10.3390/ph17010026. Pharmaceuticals (Basel). 2023. PMID: 38256860 Free PMC article.
-
Production of high purity 47Sc from proton irradiation of natural vanadium targets.EJNMMI Radiopharm Chem. 2024 Dec 18;9(1):89. doi: 10.1186/s41181-024-00321-8. EJNMMI Radiopharm Chem. 2024. PMID: 39692853 Free PMC article.
-
Synthesis of DOTA-Based 43Sc Radiopharmaceuticals Using Cyclotron-Produced 43Sc as Exemplified by [43Sc]Sc-PSMA-617 for PSMA PET Imaging.Methods Protoc. 2025 Jun 4;8(3):58. doi: 10.3390/mps8030058. Methods Protoc. 2025. PMID: 40559446 Free PMC article.
-
Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.Int J Mol Sci. 2024 May 29;25(11):5954. doi: 10.3390/ijms25115954. Int J Mol Sci. 2024. PMID: 38892142 Free PMC article. Review.
References
-
- Roesch F., Martin M. Radiometal-theranostics: The first 20 years. J. Radioanal. Nucl. Chem. 2023;332:1557–1576. doi: 10.1007/s10967-022-08624-3. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources